Phase 3 - Epidemiology

Relevant Publications

Improved Utilization Rate in Solid Organ Donors ≥80 Years: The 7-Year Tuscany Experience.

Issue Release: 2026

High-Throughput RPLC-MS/MS Quantification of Short- and Medium-Chain Fatty Acids.

Issue Release: 2025

Intravenous liposomal irinotecan in metastatic triple-negative breast cancer after ≥ 2 prior lines of chemotherapy: a phase Ib study.

Issue Release: 2025

Comparative evaluation of non-contrast MRI versus gadoxetic acid-enhanced abbreviated protocols in detecting colorectal liver metastases.

Issue Release: 2025

Developing a knowledge transfer and exchange strategy for a clinical trials unit.

Issue Release: 2025

Employing a Phased, Interdisciplinary Approach Across Healthcare and School Settings: mHealth Adaptations for Youth with Autism Spectrum Disorder At-Risk of Experiencing Obesity.

Issue Release: 2025

Net energy of grains for dairy goats differed with processing methods and grain types.

Issue Release: 2025

Salvage-line of Capecitabine Plus Oxaliplatin Therapy (XELOX) for Patients With Inoperable/Advanced Gastric Cancer Resistant/Intolerant to Cisplatin (OGSG1403).

Issue Release: 2025

Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-The Phase III MECCA Trial.

Issue Release: 2025

Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine.

Issue Release: 2025

Artifacts at Cardiac MRI: Imaging Appearances and Solutions.

Issue Release: 2025

Meeting summary: Global vaccine and immunization research forum, 2023.

Issue Release: 2025

Application of Large Language Models in Medical Training Evaluation-Using ChatGPT as a Standardized Patient: Multimetric Assessment.

Issue Release: 2025

A Drosophila cardiac myosin increases jump muscle stretch activation and shortening deactivation.

Issue Release: 2025

A multicenter, randomized, double-blind, placebo-controlled phase 3 study of Socazolimab or placebo combined with carboplatin and etoposide in the first-line treatment of extensive-stage small cell lung cancer.

Issue Release: 2025

A paradigm shift for evaluating natural attenuation of radioactive iodine in soils and sediments: Species-specific mechanisms and pathways.

Issue Release: 2025

Intestinal barrier function, caecal microbiota and growth performance of thermoneutral or heat stressed broiler chickens fed reduced crude protein diets supplemented with guanidinoacetic acid.

Issue Release: 2025

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study.

Issue Release: 2025

Cemiplimab in recurrent cervical cancer: Final analysis of overall survival in the phase III EMPOWER-Cervical 1/GOG-3016/ENGOT-cx9 trial.

Issue Release: 2025

Safety and efficacy of valoctocogene roxaparvovec with prophylactic glucocorticoids: 1-year results from the phase 3b, single-arm, open-label GENEr8-3 study.

Issue Release: 2025

How is Geographical Spread Monitored?

What are the Advantages of Using Spectrophotometry in Epidemiological Studies?

How is Hydration Status Measured?

How to Interpret Epidemiological Figures?

Why is Data Fields Completeness Important?

What Are the Strategies for Controlling Pathogenic Microorganisms?

Why are Predictive Biomarkers Important?

What is Stratification in Epidemiology?

Why is Predictive Analytics Important in Epidemiology?

How to Educate Healthcare Providers?

Phase 3 - Epidemiology

Relevant Publications

Partnered Content Networks

Relevant Topics